0000899243-17-004420.txt : 20170217
0000899243-17-004420.hdr.sgml : 20170217
20170217075901
ACCESSION NUMBER: 0000899243-17-004420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170217
FILED AS OF DATE: 20170217
DATE AS OF CHANGE: 20170217
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Li Bin
CENTRAL INDEX KEY: 0001668219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17619756
MAIL ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yu Fan
CENTRAL INDEX KEY: 0001668029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17619757
MAIL ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABG Management Ltd
CENTRAL INDEX KEY: 0001668027
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17619758
BUSINESS ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
BUSINESS PHONE: (852)31219699
MAIL ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ally Bridge LB Healthcare Master Fund Ltd
CENTRAL INDEX KEY: 0001667354
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17619760
BUSINESS ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
BUSINESS PHONE: (852)31219699
MAIL ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ally Bridge LB Management Ltd
CENTRAL INDEX KEY: 0001668028
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17619759
BUSINESS ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
BUSINESS PHONE: (852)31219699
MAIL ADDRESS:
STREET 1: UNIT 3002-04,30TH FLOOR,GLOUCESTER TOWER
STREET 2: THE LANDMARK,15 QUEEN'S ROAD CENTRAL
CITY: HONG KONG
STATE: K3
ZIP: 000000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-17
1
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001667354
Ally Bridge LB Healthcare Master Fund Ltd
UNIT 3002-3004,30TH FLR,GLOUCESTER TOWER
THE LANDMARK, 15 QUEEN'S ROAD CENTRAL
HONG KONG
0
0
0
1
Former member, 10% owner group
0001668028
Ally Bridge LB Management Ltd
UNIT 3002-3004,30TH FLR,GLOUCESTER TOWER
THE LANDMARK, 15 QUEEN'S ROAD CENTRAL
HONG KONG
0
0
0
1
See Remarks
0001668027
ABG Management Ltd
UNIT 3002-3004,30TH FLR,GLOUCESTER TOWER
THE LANDMARK,15 QUEEN'S ROAD CENTRAL
HONG KONG
0
0
0
1
See Remarks
0001668029
Yu Fan
UNIT 3002-3004,30TH FLR,GLOUCESTER TOWER
THE LANDMARK,15 QUEEN'S ROAD CENTRAL
HONG KONG
0
0
0
1
See Remarks
0001668219
Li Bin
UNIT 3002-3004,30TH FLR,GLOUCESTER TOWER
THE LANDMARK,15 QUEEN'S ROAD CENTRAL
HONG KONG
0
0
0
1
See Remarks
Ally Bridge LB Healthcare Master Fund Limited (the "Master Fund") directly owns 678,077 shares of Common Stock. Ally Bridge LB Management Limited ("LB Management") owns the sole voting share of the Master Fund. Mr. Fan Yu and Mr. Bin Li are the shareholders and directors of LB Management, and Mr. Yu is the shareholder and director of ABG Management Limited. LB Management, by virtue of it being the holder of the sole voting share of the Master Fund, and each of Mr. Yu and Mr. Li, by virtue of being a shareholder and director of LB Management, may be deemed to have voting control and investment discretion over the shares held by the Master Fund. Each of LB Management, ABG Management Limited, Mr. Yu and Mr. Li disclaims beneficial ownership of such securities and this Form 4 shall not be deemed an admission that any of them is the beneficial owner of, or has any pecuniary interest in, such securities for any purposes.
On February 17, 2017, ABG Management Limited delivered a notice to the other members of the Consortium ("Termination Notice") to withdraw from the Consortium, and the Consortium Agreement was thereby terminated with respect to ABG Management Limited, as described in that certain statement on Schedule 13D filed on February 17, 2017. As a result, the Reporting Persons are no longer party to any agreement, arrangement or understanding with respect to securities of the Issuer that might deem them to be in a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934. The Reporting Persons together do not beneficially own more than 10% of the outstanding shares of Common Stock.
Ally Bridge LB Healthcare Master Fund Limited, /s/ Bin Li, Director
2017-02-17
Ally Bridge LB Management Limited, /s/ Bin Li, Director
2017-02-17
ABG Management Limited, /s/ Fan Yu, Director
2017-02-17
/s/ Fan Yu
2017-02-17
/s/ Bin Li
2017-02-17